PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA FDN INC

EIN: 526063009 501(c)(3)

WASHINGTON, DC

Total Revenue
$4,293,133
Total Expenses
$4,981,861
Total Assets
$27,568,119
Net Assets
$26,027,434
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1965
Legal Domicile
DC
Phone
2025727756
Tax Period
2024-01-01 to 2024-12-31

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA FDN INC, founded in 1965, is a community nonprofit that reported $4.3M in total revenue in fiscal year 2024. Expenses of $5.0M exceeded revenue, resulting in a 16% operating deficit.

Mission

THE PHRMA FOUNDATION WORKS TO IMPROVE PUBLIC HEALTH BY PROACTIVELY INVESTING IN INNOVATIVE RESEARCH, EDUCATION AND VALUE DRIVEN HEALTH CARE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $3,705,380
Program Service Revenue $0
Investment Income $587,753
Other Revenue $0
TOTAL REVENUE $4,293,133

Expense Breakdown

Grants Paid $3,479,307
Salaries & Benefits $1,136,663
Fundraising Expenses $3,325
Program Expenses $4,405,267
Other Expenses $365,891
TOTAL EXPENSES $4,981,861

Year-over-Year Comparison

2024 2023 Change
Revenue $4,293,133 $4,244,730 +0.0%
Expenses $4,981,861 $4,366,003 +0.1%
Net Income $-688,728 $-121,273 +4.7%
Key Indicators
✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
8
Independent Members
8
Employees
4
Volunteers
80

Governance Policies

✗ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
4
$587,905
Total Directors
11
$0
Key Employees
0
$0
Highest Compensated
2
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
ANDREW PLUMP MD PHD CHAIRMAN 1.0
Officer Director
$0 $0 $0
DONATELLO CROCETTA TREASURER (AS OF 12/24) 1.0
Officer Director
$0 $0 $0
IRIS LOEW-FRIEDRICH MD TREASURER (THRU 12/24) 1.0
Officer Director
$0 $0 $0
AIDA HABTEZION MD MSC FRCP DIRECTOR 1.0
Director
$0 $0 $0
ARAN MAREE MB BCH MRCIP DIRECTOR (THRU 10/24) 1.0
Director
$0 $0 $0
DANIEL SKOVRONSKY MD PhD DIRECTOR 1.0
Director
$0 $0 $0
GEORGE ADDONA PHD DIRECTOR 1.0
Director
$0 $0 $0
JOHN REED MD PhD DIRECTOR (AS OF 12/24) 1.0
Director
$0 $0 $0
LORI REILLY Esq EX OFFICIO MEMBER 1.0
Director
$0 $0 $0
MAHA RADHAKRISHNAN MD DIRECTOR (THRU 03/24) 1.0
Director
$0 $0 $0
ROBERT PLENGE MD PHD DIRECTOR 1.0
Director
$0 $0 $0
AMY MILLER PRESIDENT 37.5
Officer
$515,068 $72,837 $587,905
EMILY ORTMAN SENIOR DIRECTOR 37.5
Highest
$198,869 $58,730 $257,599
JOANNE WESTPHAL DIRECTOR 37.5
Highest
$178,835 $36,213 $215,048
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 $4,293,133 $4,981,861 $27,568,119 $-688,728
2024 $4,293,133 $4,981,861 $27,568,119 $-688,728
2023 $4,244,730 $4,366,003 $24,481,309 $-121,273
2022 $3,902,642 $4,077,991 $22,787,225 $-175,349
2021 $3,693,166 $4,358,423 $26,230,760 $-665,257
2020 $5,133,283 $4,843,015 $24,587,050 $290,268
2019 $4,815,154 $5,181,735 $23,711,048 $-366,581
2018 $5,190,784 $4,129,057 $21,895,305 $1,061,727
Explore More Nonprofits
→Top 100 Nonprofits in District of Columbia →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA FDN INC with other nonprofits in District of Columbia and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.